Pseudomonal sepsis with subcutaneous nodules in an HIV-infected individual with high CD4 counts.
Tariq
Shema
S
Hameed
Saira
S
Tyrer
Mervyn
M
Johnson
Margaret
M
Lipman
Marc
M
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D019380:Anti-HIV Agents / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D015496:CD4-Positive T-Lymphocytes; D005839:Gentamicins / Q000627:therapeutic use; D005938:Glucocorticoids / Q000009:adverse effects; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D018655:Lymphocyte Count; D008297:Male; D008875:Middle Aged; D010397:Penicillanic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D010878:Piperacillin / Q000627:therapeutic use; D011552:Pseudomonas Infections / Q000209:etiology* / Q000276:immunology / Q000628:therapy; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification*; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications / Q000188:drug therapy; D012121:Respiration, Artificial; D018805:Sepsis / Q000209:etiology* / Q000628:therapy; D012871:Skin Diseases / Q000209:etiology* / Q000628:therapy; D000078142:Tazobactam; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D019380:Anti-HIV Agents; D005839:Gentamicins; D005938:Glucocorticoids; D010397:Penicillanic Acid; D000078142:Tazobactam; D010878:Piperacillin